At the time of writing, Merck & Co Inc [MRK] stock is trading at $100.98, up 1.74%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MRK shares have gain 1.86% over the last week, with a monthly amount drifted -0.02%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Merck & Co Inc [NYSE: MRK] stock has seen the most recent analyst activity on January 08, 2025, when Truist downgraded its rating to a Hold but kept the price target unchanged to $110 for it. Previously, BMO Capital Markets downgraded its rating to Market Perform on December 20, 2024, and dropped its price target to $105. HSBC Securities upgraded its rating to a Buy but stick to its price target of $130 on December 04, 2024. Wolfe Research initiated its recommendation with a Peer Perform. Daiwa Securities downgraded its rating to Neutral for this stock on November 11, 2024. In a note dated October 17, 2024, Bernstein initiated an Mkt Perform rating and provided a target price of $115 on this stock.
For the past year, the stock price of Merck & Co Inc fluctuated between $94.48 and $134.63. Currently, Wall Street analysts expect the stock to reach $135.83 within the next 12 months. Merck & Co Inc [NYSE: MRK] shares were valued at $100.98 at the most recent close of the market. An investor can expect a potential return of 34.51% based on the average MRK price forecast.
Analyzing the MRK fundamentals
According to Merck & Co Inc [NYSE:MRK], the company’s sales were 62.89B for trailing twelve months, which represents an 4.42% jump. Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at 0.24%, Pretax Profit Margin comes in at 0.22%, and Net Profit Margin reading is 0.19%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is 0.29 and Total Capital is 0.17. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.86.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 99.59 points at the first support level, and at 98.21 for the second support level. However, for the 1st resistance point, the stock is sitting at 101.76, and for the 2nd resistance point, it is at 102.55.
Ratios To Look Out For
It is important to note that Merck & Co Inc [NYSE:MRK] has a current ratio of 1.36. Further, the Quick Ratio stands at 1.15, while the Cash Ratio is 0.49. Considering the valuation of this stock, the price to sales ratio is 4.06, the price to book ratio is 5.75 and price to earnings (TTM) ratio is 21.15.
Transactions by insiders
Recent insider trading involved Merck & Co., Inc., 10% Owner, that happened on Mar 11 ’24 when 21.4 million shares were purchased. EVP & CFO, Litchfield Caroline completed a deal on Feb 14 ’24 to sell 38291.0 shares. Meanwhile, Chairman, CEO & President Davis Robert M sold 0.15 million shares on Feb 13 ’24.
